These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 27275098)
1. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer. Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098 [TBL] [Abstract][Full Text] [Related]
2. Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer. Tian W; Jia Y; Yuan K; Huang L; Nadolny C; Dong X; Ren X; Liu J Helicobacter; 2014 Feb; 19(1):9-16. PubMed ID: 24118166 [TBL] [Abstract][Full Text] [Related]
3. Serum Helicobacter pylori FliD antibody and the risk of gastric cancer. Li H; Zhang B; Hu X; Dong Y; Fan Q; Guo F; Ren X; Zhou H; Tian W; Zhao Y Oncotarget; 2016 Apr; 7(16):22397-408. PubMed ID: 26968951 [TBL] [Abstract][Full Text] [Related]
4. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. Hamashima C; Sasazuki S; Inoue M; Tsugane S; BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154 [TBL] [Abstract][Full Text] [Related]
5. Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Zhao Z; Li Y; Liu S; Fu W Tumour Biol; 2014 Dec; 35(12):12217-24. PubMed ID: 25168369 [TBL] [Abstract][Full Text] [Related]
6. Immune response to a 26-kDa protein, alkyl hydroperoxide reductase, in Helicobacter pylori-infected Mongolian gerbil model. Yan J; Kumagai T; Ohnishi M; Ueno I; Ota H Helicobacter; 2001 Dec; 6(4):274-82. PubMed ID: 11843959 [TBL] [Abstract][Full Text] [Related]
7. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer. Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg. Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521 [TBL] [Abstract][Full Text] [Related]
9. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284 [TBL] [Abstract][Full Text] [Related]
10. Production of polyclonal antibody against alkyl hydroperoxide reductase of Helicobacter pylori and its antigenicity. Mohammadian T; Doosti M; Paknejad M; Siavoshi F; Massarrat S; Soukhtanloo M Hybridoma (Larchmt); 2008 Dec; 27(6):481-5. PubMed ID: 19108621 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Shiota S; Yamaoka Y Biomark Med; 2014; 8(9):1127-37. PubMed ID: 25402582 [TBL] [Abstract][Full Text] [Related]
13. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort. Yang JJ; Yang JH; Kim J; Ma SH; Cho LY; Ko KP; Shin A; Choi BY; Kim HJ; Han DS; Eun CS; Song KS; Kim YS; Chang SH; Shin HR; Kang D; Yoo KY; Park SK Int J Cancer; 2013 May; 132(9):2148-56. PubMed ID: 23001699 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population. Sun L; Tu H; Liu J; Gong Y; Xu Q; Jing J; Dong N; Yuan Y Scand J Gastroenterol; 2014 Oct; 49(10):1164-72. PubMed ID: 25157583 [TBL] [Abstract][Full Text] [Related]
15. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139 [TBL] [Abstract][Full Text] [Related]
16. Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer. Ayala G; Flores-Luna L; Hernández-Amaro D; Mendoza-Hernández G; Chihu-Amparán L; Bernal-Sahagún F; Camorlinga M; Lazcano-Ponce E; Torres J Cancer Causes Control; 2011 Oct; 22(10):1425-34. PubMed ID: 21779758 [TBL] [Abstract][Full Text] [Related]
17. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. Li BS; Zhao YL; Guo G; Li W; Zhu ED; Luo X; Mao XH; Zou QM; Yu PW; Zuo QF; Li N; Tang B; Liu KY; Xiao B PLoS One; 2012; 7(7):e41629. PubMed ID: 22860003 [TBL] [Abstract][Full Text] [Related]
19. Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model. Kotiw M; Johnson M; Pandey M; Fry S; Hazell SL; Netter HJ; Good MF; Olive C Clin Vaccine Immunol; 2012 Feb; 19(2):268-76. PubMed ID: 22205658 [TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori CagA(+) infection in gastric cancer patients]. Ławniczak M; Starzyńska T Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]